Large Molecule Patents
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| US7807155 | NA | IL-17 antagonistic antibodies |
Feb, 2030
(5 years from now) | Active |
Ingredients:
Cosentyx contains Secukinumab as an active ingredient
Activity Alert